# A Study of Pregnenolone in the Treatment of Individuals With Autism

> **NCT01881737** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 15 (actual)

## Conditions studied

- Autistic Disorder

## Interventions

- **DRUG:** Pregnenolone

## Key facts

- **NCT ID:** NCT01881737
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01881737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01881737, "A Study of Pregnenolone in the Treatment of Individuals With Autism". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01881737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*